Description
N-Acetyl-L-cysteine exhibits antioxidative, mucolytic, anti-inflammatory, antiviral, antipsychotic, and neuromodulatory activities. N-Acetyl-L-cysteine has clinically been used to treat acetaminophen overdose; it is occasionally commercially sold as a supplement. N-Acetyl-L-cysteine acts as a scavenger of ROS, decreasing oxidative stress in a variety of models. In vitro, this compound also inhibits TNF-α-induced increases in IL-6 release and NF-κB activation. N-Acetyl-L-cysteine also inhibits hepatitis B virus replication by suppressing viral assembly. Clinically, N-acetyl-L-cysteine displays potential benefit in the treatment of various mood disorders as it modulates reward and reinforcement signaling.
References
Lim JH, Lee YM, Park SR, et al. Anticancer activity of hispidin via reactive oxygen species-mediated apoptosis in colon cancer cells. Anticancer Res. 2014 Aug;34(8):4087-93. PMID: 25075033.
Grosicka-Maciąg E, Szumiło M, Czeczot H, et al. Modulation of antioxidant defense system by the dithiocarbamate fungicides Maneb and Zineb in Chinese hamster V79 cells and the role of N-acetyl-L-cysteine. Food Chem Toxicol. 2013 Oct;60:130-4. PMID: 23871785.
Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011 Mar;36(2):78-86. PMID: 21118657.
Weiss L, Hildt E, Hofschneider PH. Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug. Antiviral Res. 1996 Aug;32(1):43-53. PMID: 8863995.
Shibanuma M, Kuroki T, Nose K. Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett. 1994 Oct 10;353(1):62-6. PMID: 7926024.
